Vaccaria hypaphorine alleviates lipopolysaccharide-induced inflammation via inactivation of NFκB and ERK pathways in Raw 264.7 cells by Haijian Sun et al.
RESEARCH ARTICLE Open Access
Vaccaria hypaphorine alleviates
lipopolysaccharide-induced inflammation
via inactivation of NFκB and ERK pathways
in Raw 264.7 cells
Haijian Sun1†, Weiwei Cai1†, Xu Wang1†, Yanling Liu2, Bao Hou1, Xuexue Zhu1 and Liying Qiu1*
Abstract
Background: Activation of macrophage is involved in many inflammation diseases. Lipopolysaccharide (LPS) is
a powerful inflammatory signal contributing to monocytes/macrophages activation associated with increased
proinflammatory cytokines expressions. We recently identified that vaccarin was expected to protect endothelial
cells from injury. Hypaphorine was abundantly found in vaccaria semen. However, the potential roles and underlying
mechanisms of vaccaria hypaphorine on macrophage inflammation have been poorly defined.
Methods: This study was designed to determine the effects of vaccaria hypaphorine on LPS-mediated inflammation
in RAW 264.7 cells.
Results: In this study, we demonstrated that vaccaria hypaphorine dramatically ameliorated LPS-induced nitric
oxide (NO) release and productions of proinflammatory cytokines including tumor necrosis factor-α (TNF-α),
interleukin-1β (IL-1β), IL-6, IL-10, monocyte chemoattractant protein 1 (MCP-1) and prostaglandin E2 (PGE2) in RAW
264.7 cells. LPS-stimulated expressions of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) were
down-regulated by vaccaria hypaphorine. Furthermore, vaccaria hypaphorine retarded LPS-induced phosphorylation
of ERK, nuclear factor kappa beta (NFκB), NFκB inhibitor IκBα, and IKKβ. Immunofluorescence staining revealed that
vaccaria hypaphorine eliminated the nuclear translocation of NFκB in LPS-treated RAW 264.7 cells.
Conclusion: It was seen that vaccaria hypaphorine counteracted inflammation via inhibition of ERK or/and NFκB
signaling pathways. Collectively, we concluded that vaccaria hypaphorine can be served as an anti-inflammatory
candidate.
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Background
Inflammation is considered as a tissue protective immune
response against injurious stimuli including damaged cells,
irritants and bacteria [1]. The process of inflammation is
regulated by initiating, maintaining and shutting signals
[2]. However, the imbalanced inflammation may induce
cellular and tissue damage in different diseases such as
atherosclerosis [3], hypertension [4], diabetes [5], cancer
[6], and neurodegenerative disorders [7].
The immune system may produce inflammation medi-
ators response to chemical, physical, or infectious stress
[1]. Macrophages are critical determinants for multiple
biological processes during the immune response [7].
Macrophages can release various cytokines and growth
factors to exert three major functions including antigen
presentation, phagocytosis, and immunomodulation dur-
ing the process of inflammation [8]. Injured or activated
macrophages may coordinate inflammatory responses
through releasing various inflammatory mediators [8].
Overproduction of pro-inflammatory cytokine by macro-
phages leads to destructive inflammation in the body [9].
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Lipopolysaccharide (LPS) acts as a switch for macro-
phages activation as evidenced by excessive expressions
in nitric oxide (NO), tumor necrosis factor-α (TNF-α),
prostaglandin E2 (PGE2), interleukin-1β (IL-1β), IL-6,
IL-10, inducible nitric oxide synthase (iNOS), and
monocyte chemoattractant protein 1 (MCP-1) [10, 11].
Pro-inflammatory stimuli mediated-upregualtion of
cyclooxygenase-2 (COX-2) is a major contributor to
PGE2 synthesis [12]. Mitogen-activated protein kinases
(MAPKs) and nuclear factor kappa beta (NFκB) signaling
pathways may be two important intracellular molecular
pathways involving inflammatory cascade response to LPS
stimulation in RAW264.7 cells [13–15].
Vaccarin is the main component of Vaccaria segetalis
seeds [16]. Vaccarin is recently identified to be a major
flavonoid glycoside [17]. The emergence of vaccarin has
attracted considerable attention due to its diverse bio-
logical activities [18]. Vaccarin dose-relatedly promoted
the proliferation, migration, tube formation and neovas-
cularization of human microvascular endothelial cells
through activation of Akt and ERK signals [19]. The
construction of bacterial cellulose-vaccarin membranes
exhibited no cytotoxicity for cell growth, which was
found to be a potential candidate for wound healing in
rat skin models [20]. We recently demonstrated that
vaccarin may protect endothelial cells from oxidative
stress-induced injury via negatively regulation of Notch
signaling [21]. We further established that vaccarin may
obviously ameliorate high glucose-mediated endothelial
cell injury by reversing cell viability and migratory ability
[22]. The existing evidence suggested that vaccarin may
function as novel therapeutic agent for endothelium dys-
function. The hypaphorine is an indole alkaloid from
Erythrina velutina that exhibits sleep promoting effects
in normal mice [23]. The hypaphorine from different
marine sources is shown to possess anti-inflammatory
properties [24]. Fungal auxin antagonist hypaphorine
obviously inhibited indole-3-acetic acid-dependent
superoxide production by competitively binding to the
putative binding site of indole-3-acetic acid [25]. Hypa-
phorine was also a key component of Vaccaria segetalis.
However, the potential roles and mechanisms of vaccaria
hypaphorine on macrophages inflammation were largely
unknown. In this study, we investigated that the possible
mechanism by which vaccaria hypaphorine protected
RAW 264.7 murine macrophages from LPS-induced in-
flammation response in vitro.
Methods
Drugs and chemicals
Vaccaria hypaphorine was purchased from Shanghai
Shifeng technology Co., Ltd.,China. Vaccaria hypaphorine
was solubilized in sterile phosphate buffer saline (PBS).
The cells including mouse macrophage Raw264.7, human
lung adenocarcinoma cell line A549 and mouse lung
cancer cell Lewis were purchased from American Type
Culture Collection (Rockville, MD, USA). Human
microvascular endothelial cells HMEC-1 was obtained
from the Health and Medicine Research of French Na-
tional Institute. Human umbilical vein endothelial cells
EA · hy926, mouse fibroblast cells L929, human breast
cancer cell line MCF-7 and mouse melanoma cells were
gifts from Tang Zhongying Institute of Hematology of
Soochow University. Mouse liver cancer cell H22 was
a gift from Department of pharmacology, Shanghai
Pharmaceutical Industry Research Institute. Cell culture
supplies were purchased from Costar (Corning Inc., Cy-
press, CA, USA). Sulforhodamine B (SRB), MCDB 131,
rhodamine B, DAPI, lipopolysaccharide and aspirin (Asp)
were purchased from Sigma Chemical Co. (St Louis, MO,
USA). RPMI-1640 medium and DMEM were obtained
from Hyclone (Logan, UT, U.S.A.). Dexamethasone (Dex)
was purchased from Shanghai biological engineering
Limited by Share Ltd. Antibody against β-tublin was
purchased from Abcam (Cambridge, MA, USA). Anti-
bodies against total or phosphorylated nuclear factor
(NF)κB, IκBα, IκB-kinase β (IKKβ) and ERK as well as
iNOS, COX-2 were obtained from Cell Signaling Technol-
ogy (Beverly, MA, USA). The goat anti-rabbit secondary
antibody was purchased from SangonBiotech (Shanghai)
Co.,Ltd. (Shanghai, China). M-PER Mammalian Protein
Extraction Reagent was purchased from Thermo scientific
(USA). RNAiso Plus reagent, SYBR® Premix Ex Taq™ and
PrimeScript™RT reagent Kit with gDNA Eraser were
purchased from Takara Co. (Takara, Otsu, Shiga, Japan).
Dex and Asp were served as positive controls.
Cell culture and treatments
Raw264.7, EA · hy926, L929 and MCF-7 cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% fetal bovine serum (FBS, Hyclone, Logan, UT,
U.S.A.) and 1 × Antibiotic-Antimycotic Solution. A549,
Lewis, B16 and H22 cells were cultured in RPMI-1640
medium supplemented with 10% fetal bovine serum and
1 × Antibiotic-Antimycotic Solution. HMEC-1 cells were
cultured in MCDB 131 medium supplemented with 10%
fetal bovine serum, 2 mM L-glutamine and 1 × Anti-
biotic-Antimycotic Solution. These cells were incubated
at 37 °C in a humidified air containing 5% CO2. The
growth medium was replaced every 2–3 day and the
cells were seeded onto petridishes or multiwell plates at
a ratio of 1–3 upon 80% confluency.
Assessment of cell viability
The sulforhodamine B (SRB) assay was used to assess
the cell viability as our previous report [21]. The cell
growth was arrested by incubation of the cells in 2%
serum medium for 24 h before treatment. The indicated
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cells were then seeded in 96-well culture plates at a
density of 5 × 103 cells/well, and stimulated with differ-
ent concentrations of vaccaria hypaphorine (6.25 μM,
12.5 μM, 25 μM, 50 μM, 100 μM, 200 μM) at 37 °C in
5% CO2 saturated humidity condition for 24 h. Finally,
the optical density (OD) was measured at 540 nm with
the aid of a Multiskan MK3 (Labsystem company). The
results were expressed as the ratio by normalizing the
targeted OD level to that of control OD.
Determination of nitric oxide (NO) levels
The levels of NO were analyzed using Griess reaction as
previously described [26, 27]. Equal volumes of N-(1-
naphthyl) ethylenediamine and sulfanilic acid were com-
bined to form the Griess reagent. The 100 μl supernatant
from each well was collected in all samples, and reacted
with 100 μl of the Griess Reagent for 30-min incubation at
room temperature. The absorbance was measured at
540 nm. The standard curves were plotted from sodium
nitrite standards (ranging from 10 to 60 μM).
Real-time quantitative PCR analysis
The mRNA levels of tumor necrosis factor-α (TNF-α),
interleukin-1β (IL-1β), IL-6, IL-10 and monocyte chemo-
attractant protein 1 (MCP-1) were detected by a fluores-
cence quantitative LightCycler 480 Real Time PCR
system (Roche, Basel, Sweden) [28]. In brief, total RNA
of each sample was extracted by Trizol reagent accord-
ing to the manufacturer’s instructions. The equal RNA
was reverse transcribed to cDNA using PrimeScript™RT
reagent Kit with gDNA Eraser (Takara, Otsu, Shiga,
Japan). The real-time quantitative PCR was performed in
triplicates by using SYBR® Premix Ex Taq™ (Takara,
Otsu, Shiga, Japan). The average cycle thresholds (Ct)
were employed to quantify fold-change. The relative
quantification of gene expression was reported as a rela-
tive quantity to the control value by using 2-△△Ct
methods. The sequences of primers were listed in the
supplemental table (Additional file 1: Table S1).
Enzyme-linked immunosorbent assay (ELISA) assay
Commercial ELISA kit was used for the measurement of
TNF-α,IL-1,IL-6,PGE2 levels (R&D Systems, Inc., Minne-
apolis, MN, USA) following the manufacturer’s protocols.
The cell culture supernatants in each sample were col-
lected and stored -20 °C prior to use. The standards or
samples diluent were added into appropriate well of spe-
cific antibody pre-coated microtiterplate and incubated for
30 min at 37 °C. The reacted microtiterplate was washed
by diluted washing buffer for 5 times. Conjugate was
added and incubated for 1 h at 37 °C and then re-washed.
The reactions were stopped with 50 μl stop solution, and
the absorbance was read at 450 nm with a microtiter plate
reader (STNERGY/H4, BioTek, Vermont, USA).
Western blot analysis
Whole cell lysates were obtained and homogenized by
RIPA buffer. The supernatant was collected by centrifu-
gation at 12,000 g for 10 min at 4 °C. Total protein
concentration in the homogenate was measured with a
protein assay kit (Santa Cruz, Dallas, TX, USA). Total
25 μg of total protein were subjected to SDS-PAGE and
electro-transferred onto nitrocellulose membrane
(Millipore, USA). The membranes were blocked with
5% nonfat milk for 1 h at room temperature before
overnight incubation with indicated primary antibodies
at 4 °C. The primary antibodies were as follows: COX-2
(1:1000), iNOS (1:1000), phosphorylation of ERK
(1:1000), ERK (1:1000), p-IκBα (1:1000), IκBα (1:1000),
p-IKKβ (1:1000), IKKβ (1:1000), p-NFκB (1:1000),
NFκB (1:1000), and β-tublin (1:1000). The membranes
were washed three times with TBST for 5 min and sub-
sequently incubated with HRP-conjugated secondary
antibody. The positive bands were captured using the
enhanced chemiluminescent.
Immunofluorescence microscopy
The stimulated Raw264.7 cells were fixed with 4% for-
maldehyde for 30 min, and then permeabilized with
0.1% Triton X-100 in PBS for 15 min. After incubation
with 10% goat serum for 30 min, and incubated with in-
dicated primary antibody rabbit anti-NFκB overnight at
4 °C. After three washes with PBS, cells were incubated
with FITC-labeled secondary antibodies for 30 min.
Nuclei were stained with 4’,6-diamidino-2-phenylindole
(DAPI) after immunofluorescence staining. Immuno-
fluorescence signals were visualized on a fluorescence
microscope (80i, Nikon, Japan).
Statistical analysis
All results were defined as mean ± S.D.. Comparisons
within two groups were made by Student’s t test. Statis-
tical analysis was performed by ANOVA/Dunnet t-test
for multiple group comparisons. A difference of P < 0.05
was considered statistically significant.
Results
Assessment of vaccaria hypaphorine on cell viability in
different cells
The different cell lines RAW264.7, L929, A549, Lewis,
H22, B16, MCF-7, HMEC-1 and EA · hy926 were
treated with various doses of vaccaria hypaphorine
(6.25, 12.5, 25, 50, 100 and 200 μM) for 24 h. SRB
assay then showed that vaccaria hypaphorine had no
significant effect on the growth of tumor cells and
endothelial cells. Vaccaria hypaphorine had no cytotoxicity
on these cells including RAW264.7 cells (Additional
file 1: Table S2).
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Effects of vaccaria hypaphorine on cell viability response
to LPS in RAW264.7 cells
To explore the anti-inflammatory effect of vaccaria
hypaphorine, vaccaria hypaphorine was treated on LPS-
induced inflammation in RAW 264.7 cells. Firstly, the
determination of optical density by SRB assay showed
that LPS exerted a slight promotion in RAW264.7 cell
proliferation, and combination application of LPS with
vaccaria hypaphorine, Dex and Asp had no obvious
effect on the proliferation of RAW264.7 cells (Additional
file 1: Figure S1).
Effect of vaccaria hypaphorine on LPS-induced inflammatory
responses in RAW264.7 cells
LPS, a Gram-negative bacterial cell wall component, is
responsible for pro-inflammatory cytokines accumula-
tion in activated macrophages [29]. Stimulation of
RAW 264.7 macrophages with LPS induced remarkable
Fig. 1 Effects of different doses of Vaccaria hypaphorine (12.5, 25 and 50 μM), Dex (100 μM) and Asp (1 mM) on the mRNA expressions of TNF-α
(a), IL-1β (b), IL-6 (c), IL-10 (d) and MCP-1(e) response to LPS (1 μg/ml)-treated RAW264.7 cells for 24 h in vitro. Values are mean ± S.D. *P < 0.05 vs.
Control, †P < 0.05 vs. LPS, †† P < 0.05 vs. Vaccaria hypaphorine (12.5 μM) + LPS. n = 6 for each group. LPS, lipopolysaccharide; Dex, dexamethasone;
Asp, aspirin; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; IL-6, interleukin-6; IL-10, interleukin-10; MCP-1, monocyte chemoattractant protein 1
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increases in mRNA levels of TNF-α (Fig. 1a), IL-1β
(Fig. 1b), IL-6 (Fig. 1c), IL-10 (Fig. 1d) and MCP-1
(Fig. 1e). Vaccaria hypaphorine markedly prevented
LPS-induced productions of IL-1β, IL-6, IL-10 and
MCP-1 (Fig. 2) in a dose-dependent manner. Vaccaria
hypaphorine effectively counteracted TNF-α mRNA
levels in LPS-challenged RAW 264.7 cells, but with
dose correlation (Fig. 1a). Both Dex and Asp exhibited
an inhibitory effect on LPS-induced inflammation
reactions at mRNA level in RAW 264.7 macrophages
(Fig. 1). In particular, pro-inflammatory cytokine pro-
ductions were suppressed more effectively by vaccaria
hypaphorine (50 μM) than by both Dex and Asp
(Fig. 1). Excessive production of NO may act as pro-
inflammatory mediators to evoke chronic inflammation
contributing tissue damages [30]. Incubation of
RAW264.7 macrophages with LPS (1 μg/ml) signifi-
cantly increased NO overproduction by more than 5
Fig. 2 Effects of different doses of Vaccaria hypaphorine (12.5, 25 and 50 μM), Dex (100 μM) and Asp (1 mM) on the TNF-α (a), IL-1β (b), IL-6 (c),
PGE2 (d) expressions and NO production (e) response to LPS (1 μg/ml)-treated RAW264.7 cells for 24 h in vitro. Values are mean ± S.D. *P < 0.05
vs. Control, †P < 0.05 vs. LPS, †† P < 0.05 vs. Vaccaria hypaphorine (12.5 μM) + LPS. n = 6 for each group. LPS, lipopolysaccharide; Dex, dexamethasone;
Asp, aspirin; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; IL-6, interleukin-6; PGE2, prostaglandin E2; NO, nitric oxide
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fold, which was effectively reduced by both vaccaria
vypaphorine and Dex as well as Asp (Fig. 1f ).
Similar to mRNA results, treatment of RAW 264.7 mac-
rophages with LPS caused enormous increases in protein
levels of key inflammatory factors including TNF-α
(Fig. 2a), IL-1β (Fig. 2b), IL-6 (Fig. 2c) and PGE2 (Fig. 2d).
The pro-inflammatory effects of LPS were suppressed by
vaccaria hypaphorine in a concentration-related fashion.
Both Dex and Asp obviously impeded LPS-induced in-
flammation reactions at protein levels of TNF-α, IL-1β,
IL-6 and PGE2 in RAW 264.7 macrophages (Fig. 2).
Effect of vaccaria hypaphorine on LPS-induced COX-2 and
iNOS in RAW264.7 cells
The iNOS in macrophages may produce excessive NO
to exert toxic effects on cells under inflammatory stimuli
such as LPS and cytokines [31]. It is accepted that mac-
rophages may induce the expression of inflammatory en-
zymes such as iNOS and COX-2 during inflammatory
responses [32]. The up-regulated iNOS and COX-2 pro-
tein expressions were obviously inhibited by vaccaria
hypaphorine (Fig. 3). The reduction in NO release by
vaccaria hypaphorine may be attributed to iNOS protein
inhibition.
Involvement of ERK or/and NFκB in protective role of
vaccaria hypaphorine in LPS-mediated inflammation in
RAW264.7 cells
It is well clarified that mitogen-activated protein kinase
ERK or NFκB transduction pathways are majorly in-
volved in LPS-induced macrophages inflammation [33].
ERK pathway may be taken as intermediate stage in the
regulation of NF-κB activation [34, 35]. Treatment of
RAW 264.7 macrophages with LPS promoted the phos-
phorylation of ERK, which was attenuated by vaccaria
hypaphorine at higher dose (Fig. 4), suggesting that the
upstream kinases for ERK may be modulated by vaccaria
hypaphorine.
Fig. 3 Effects of different doses of Vaccaria hypaphorine (12.5, 25 and 50 μM for 24 h) on the protein expressions of COX-2 or iNOS in response
to LPS-stimulated RAW264.7 cells in vitro. a, representative images showing effects of pretreatment of different concentrations of Vaccaria hypaphorine
(12.5, 25 and 50 μM), Dex (100 μM) and Asp (1 mM) on COX-2 or iNOS levels of RAW264.7 cells response to LPS (1 μg/ml). b, quantitative analysis
of COX-2 or iNOS protein expressions in different groups. Values are mean ± S.D. *P < 0.05 vs. Control, †P < 0.05 vs. LPS, †† P < 0.05 vs. Vaccaria
hypaphorine (12.5 μM) + LPS. n = 6 for each group. NO, nitric oxide; LPS, lipopolysaccharide; Dex, dexamethasone; Asp, aspirin. iNOS, induced
nitric oxide (NO); COX-2, cyclooxygenase-2
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Nucleus translocation of p65-NFκB is considered as a
prerequisite for the transcription [36]. The phosphorylation
of IκBα is identified to be upstream events of p65-NFκB
translocation. Activation IKKβ is crucial for phosphorylation
of IκBα and translocation of NFκB in a canonical pathway
[37]. Exposure of RAW 264.7 macrophages to LPS signifi-
cantly augmented the phosphorylated protein levels of
NFκB, IκBα and IKKβ in RAW 264.7 macrophages, whereas
vaccaria hypaphorine (50 μM) markedly inhibited the LPS-
induced production of phosphorylated IκBα (Fig. 5a), IKKβ
(Fig. 5b) and NFκB (Fig. 5c). Furthermore, LPS promoted
the nuclear accumulation of p65-NFκB as evidenced by im-
munofluorescence staining, and which was effectively atten-
uated by pretreatment with vaccaria hypaphorine (Fig. 6).
Discussion
Inflammation is an orchestrated and complex event
upon a wide range of harmful stimuli such as infection,
tissue injury and stimulant [38]. Inflammation may have
two paradoxical activities reflected by protection follow-
ing pernicious stimuli or tissue injury [39]. Dysregulated
or misdirected inflammation is a detrimental factor for
pathogenesis of many diseases [40]. The complementary
and alternative approaches have attracted wide concerns
for their protective effects against inflammatory responses
in many diseases [41]. In the present study, we explored
whether vaccaria hypaphorine exerted a protection from
LPS-mediated inflammation in RAW264.7 cells and
investigated the underlying mechanism of vaccaria
hypaphorine. We identified that vaccaria hypaphorine
abrogated inflammatory responses induced by LPS via
inhibition of NFκB and ERK signaling pathways.
Natural products including Traditional Chinese herbs
have obtained enormous interest for their clinical applica-
tion value, and they may provide a promising strategy to
prevent chronic inflammatory diseases [42]. Macrophages
Fig. 4 Effects of different doses of Vaccaria hypaphorine (12.5, 25 and 50 μM for 24 h) on the total or phosphorylated protein expressions of ERK
in response to LPS-stimulated RAW264.7 cells in vitro. a, representative images of Western blot showing effects of pretreatment of different
concentrations of Vaccaria hypaphorine (12.5, 25 and 50 μM), Dex (100 μM) and Asp (1 mM) on phosphorylated protein expressions of ERK of
RAW264.7 cells response to LPS (1 μg/ml). b, quantitative analysis of phosphorylation of ERK. Values are mean ± S.D. *P < 0.05 vs. Control, †P < 0.05 vs.
LPS, †† P < 0.05 vs. Vaccaria hypaphorine (12.5 μM) + LPS. n = 6 for each group. LPS, lipopolysaccharide; Dex, dexamethasone; Asp, aspirin
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are responsible for initiation, maintenance, and resolution
of inflammation [11]. A growing body of experiments dem-
onstrated that activated macrophages may be critical deter-
minants in the development of inflammatory reactions as
reflected by overproduction of different pro-inflammatory
mediators and cytokines [8]. Mounting evidence demon-
strates that LPS acts on toll-like receptor 4 (TLR4) to trigger
inflammation cascade in macrophages via excessive produc-
tions of TNF-α, IL-1β, IL-6, IL-10 and MCP-1 [43–45]. In
this study, we tested whether vaccaria hypaphorine exerted
potential anti-inflammatory activity in LPS-challenged
RAW 264.7 macrophage cells. Herein, our results showed
that the increased mRNA levels of TNF-α, IL-1β, IL-6, IL-
10 and MCP-1, and protein expressions of TNF-α, IL-1β,
and IL-6 in LPS-treated RAW264.7 cells, these results were
in accordance with various published papers [46–50]. It is
interesting that vaccaria hypaphorine dose-dependently alle-
viated mRNA levels of TNF-α, IL-1β, IL-6, IL-10 and MCP-
1, but only middle or high dose of vaccaria hypaphorine
abolished the protein expressions of TNF-α, IL-1β, and IL-6
in RAW264.7 cells in response to LPS. The different tran-
scriptional or post-translational modifications by various
doses of vaccaria hypaphorine may contribute to the differ-
ences in mRNA or protein levels of inflammatory mediators
in LPS-incubated RAW264.7 cells.
NO is identified to be a pro-inflammatory molecule in
the development of various inflammatory diseases. The
production of NO is widely taken as a hallmark for
macrophage activation, which is indispensable for the
pathogenesis of inflammatory diseases [51]. The activated
macrophages can stimulate iNOS expressions to generate
NO in culture medium. Blockade of iNOS and NO expres-
sions was used to assess the anti-inflammatory potential of
many traditional herbs [49]. A few natural products are be-
lieved to inhibit the overproduction of NO. Vermelhotin
abrogates the iNOS expressions and NO production by se-
lectively inhibiting p38 activation in LPS-stimulated RAW
264.7 macrophage cells [52]. Sterols isolated from Heri-
cium erinaceum exerts inhibitory effects against TNF-α
and NO production in RAW 264.7 macrophage cells re-
sponse to LPS [53]. The pseudohypericin, amentoflavone,
quercetin, and chlorogenic acid in Hypericum perforatum
attenuate the PGE2 and NO expressions via activating sup-
pressor of cytokine signaling 3 (SOCS3) in LPS-incubated
Fig. 5 Effects of different doses of Vaccaria hypaphorine (12.5, 25 and 50 μM for 24 h) on the protein expressions of NFκB、IκBα、IKKβ and their
phosphorylated protein in response to LPS-stimulated RAW264.7 cells in vitro. a, representative images of Western blot showing effects of pretreatment
of different concentrations of Vaccaria hypaphorine (12.5, 25 and 50 μM), Dex (100 μM) and Asp (1 mM) on NFκB, IκBα, IKKβ and their phosphorylated
protein levels of RAW264.7 cells response to LPS (1 μg/ml). b, quantitative analysis of phosphorylation of IκBα. c, quantitative analysis of phosphorylation
of IKKβ. d, quantitative analysis of phosphorylation of NF-κB. Values are mean ± S.D. *P < 0.05 vs. Control, †P < 0.05 vs. LPS, †† P < 0.05 vs. Vaccaria
hypaphorine (12.5 μM) + LPS. n = 6 for each group. LPS, lipopolysaccharide; Dex, dexamethasone; Asp, aspirin
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RAW 264.7 macrophages [54]. In this study, we disclosed
that three concentrations of vaccaria hypaphorine had
similar inhibitory effect on NO levels, but vaccaria hypa-
phorine dose-relatedly compromised the increased iNOS
expressions in RAW 264.7 macrophages induced by LPS.
These results implied that vaccaria hypaphorine was an
anti-inflammatory natural product by suppressing NO pro-
duction in RAW 264.7 cells. COX-2 is largely involved in
the synthesis of PGE2, which lead to inflammatory symp-
toms in RAW 264.7 macrophages [55]. We also revealed
that vaccaria hypaphorine obviously blocked LPS-
upregulated protein expressions of COX-2 and PGE2
mRNA levels in a dose-dependent manner. These results
hinted that vaccaria hypaphorine may be vital to control
immune responses through inhibition of pro-inflammatory
cytokines and mediators.
NFκB is a pro-inflammatory transcription factor, which
is pivotal for inflammation cytokines deposition and
COX2 up-regulation [56]. Several studies have shown that
translocation of NFκB from the cytoplasm to the nucleus
may be crucial for overexpression of inflammatory media-
tors such as COX-2, iNOS, TNF-α, IL-1β, IL-6, IL-10 and
MCP-1 [57]. The phosphorylation of IκBα and IKKβ is a
vital event for NFκB activation [58]. It is established that
activation of ERK may be partially responsible for LPS-
induced iNOS and COX-2 expressions in RAW 264.7
macrophages [49, 55]. In this study, our results showed
that the phosphorylation of ERK, IκBα, IKKβ, NFκB and
NFκB nuclear translocation were markedly reversed by
vaccaria hypaphorine in LPS-treated RAW 264.7 macro-
phages. These data indicated that vaccaria hypaphorine
may prevent LPS-initiated inflammatory cytokine produc-
tions including TNF-α, IL-1β, IL-6, IL-10 and MCP-1, as
well as inflammation related enzymes including COX-2
and iNOS in RAW 264.7 cells via inhibition of NFκB and
ERK signaling pathways (Additional file 1: Figure S2).
Interestingly, our results showed that high dose or low
dose of vaccaria hypaphorine counteracted the phosphor-
ylation of IκBα, IKKβ and NF-κB, but vaccaria hypaphor-
ine at middle dose had no effect on phosphorylation of
IκBα, IKKβ and NFκB. These unexpected results will be
further elucidated in our next researches.
Taken together, our results provide evidence that vaccaria
hypaphorine may be proposed as an anti-inflammatory
candidate via decreasing the levels of COX-2, iNOS,
TNF-α, IL-6, IL-10, PGE2, and IL-10 and MCP-1. The
disruption of NFκB and ERK pathways may be the pos-
sible cellular signaling mechanisms whereby vaccaria
hypaphorine exerted the anti-inflammatory response in
LPS-stimulated RAW264.7 cells.
Conclusions
For the first time, our results demonstrate that vac-
caria hypaphorine plays an essential role in the anti-
inflammatory action response to LPS through the
inhibition of NFκB and ERK pathways, which may
provide a novel therapeutic strategy for treatment of
inflammation-associated diseases.
Fig. 6 Immunofluorescence staining showing the p65-NFκB distribution in RAW264.7 cells. Nuclei were stained by DAPI (blue). These representative
photomicrographs indicated that Vaccaria hypaphorine (50 μM for 24) diminished nuclear translocation of p65-NFκB in LPS(1 μg/ml)-incubated
RAW264.7 cells
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Additional file
Additional file 1: Table S1. Primer and its parameters of RT-PCR analysis.
Table S2. Effects of Vaccaria hypaphorine on survival rate of different
cell lines. Figure S1. Effects of different doses of Vaccaria Hypaphorine
(12.5, 25 and 50 μM for 24 h) on the cell survival rate in response to
LPS-stimulated RAW264.7 cells in vitro. (A), effects of pretreatment of
different concentrations of Vaccaria Hypaphorine (12.5, 25 and 50 μM), Dex
(100 μM) and Asp (1 mM) on cell viability of LPS (1 μg/ml)-challenged
RAW264.7 cells determined with SRB assay. Values are mean ± S.D. LPS,
lipopolysaccharide; Dex, Dexamethasone; Asp, Aspirin; Sulforhodamine B,
SRB. Figure S2. Schematic indicating the inhibition of vaccaria hypaphorine
to alleviate inflammation response by LPS in RAW264.7 cells. (DOCX 391 kb)
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SRB: Sulforhodamine B; TNF-α: Tumor necrosis factor-α
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